Guidelines: Finnish Breast Cancer Association Guideline (Finland): Difference between revisions
m (Update categories.) |
m (Update categories.) |
||
| Line 27: | Line 27: | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | ||
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | |||
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span> | |||
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | |||
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span> | |||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | |||
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | |||
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> | |||
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | |||
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span> | |||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | |||
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | |||
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> | |||
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span> | |||
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> | |||
<span style="display:none">hasCancerType::unknown</span> | |||
Revision as of 12:12, 6 December 2025
Go back to Finland page
Primary purpose: To provide comprehensive, evidence-based recommendations for the diagnosis, treatment, and follow-up care of breast cancer patients to ensure optimal patient outcomes and standardized clinical practices.
Sponsor, manager or home institution: Finnish Breast Cancer Group.
Type of information: medical procedures, screening, cancer prevalence, risk of cancer, palliative care. Provides comprehensive guidelines on breast cancer, covering diagnostic pathways, staging, triple diagnostics, imaging follow-up, hereditary breast cancer, core needle biopsy, multidisciplinary treatment planning, surgical and reconstruction options, radiotherapy, neoadjuvant and adjuvant drug treatments, hormonal therapies, chemotherapy, management of recurrent and metastatic breast cancer, special cases like pregnancy, and follow-up care. Click here to learn more.
Cancer areas of interest: C50: Breast cancer. Click here to learn more.
Access to information: Click here to access.